Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| SLAF5 | Q9UIB8 | SLAM family member 5 (Cell surface antigen MAX.3) (Hly9-beta) (Leukocyte differentiation antigen CD84) (Signaling lymphocytic activation molecule 5) (CD antigen CD84) | CD markersPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 8 | 0.63 | |||
| CADH6 | P55285 | Cadherin-6 (Kidney cadherin) (K-cadherin) | Plasma proteinsPredicted membrane proteins | 1 | Ovarian cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 7 | 0.63 | ||
| CD19 | P15391 | B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19) | CD markersDisease related genesFDA approved drug targets | 1 | Acute myeloid leukaemiaB-cell lymphomaDiabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 7 | 0.63 | ||
| CSPG5 | O95196 | Chondroitin sulfate proteoglycan 5 (Acidic leucine-rich EGF-like domain-containing brain protein) (Neuroglycan C) | Predicted membrane proteinsPredicted secreted proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 7 | 0.63 | |||
| DSC2 | Q02487 | Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III) | Disease related genesHuman disease related genesPlasma proteins | 1 | Cardiomyopathy | Adhesion and uptake mediationFusion and delivery mediation | 7 | 0.63 | ||
| MRP6 | O95255 | ATP-binding cassette sub-family C member 6 (EC 7.6.2.-) (EC 7.6.2.3) (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E) (MOAT-E) (Multidrug resistance-associated protein 6) | 17 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 7 | 0.63 | ||||
| PAR4 | Q96RI0 | Proteinase-activated receptor 4 (PAR-4) (Coagulation factor II receptor-like 3) (Thrombin receptor-like 3) | 7 | Fusion and delivery mediationImmune mediationMetabolism mediation | 7 | 0.63 | ||||
| AA1R | P30542 | Adenosine receptor A1 | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Acute diabetic complicationAllergic/hypersensitivity disorderCardiac arrhythmia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | ||
| ANO10 | Q9NW15 | Anoctamin-10 (Transmembrane protein 16K) | Disease related genesHuman disease related genesPotential drug targets | 8 | Clinical-translation mediationFusion and delivery mediation | 6 | 0.63 | |||
| CADM3 | Q8N126 | Cell adhesion molecule 3 (Brain immunoglobulin receptor) (Immunoglobulin superfamily member 4B) (IgSF4B) (Nectin-like protein 1) (NECL-1) (Synaptic cell adhesion molecule 3) (SynCAM3) (TSLC1-like protein 1) (TSLL1) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Charcot-Marie-Tooth disease | Adhesion and uptake mediationReceptor-signaling mediation | 6 | 0.63 |